Enzymotec Announces Publication Acceptance Of Clinical Study Results On K-REAL™ Usage Health Benefits

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MIGDAL HA’EMEQ, Israel, Dec. 3, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today the acceptance for future publication of its clinical study results evaluating the health benefits of K-REAL™, krill oil, compared with fish oil.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC